PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia (2019) Bastian L, Schroeder MP, Eckert C, Schlee C, Tanchez JO, Kämpf S, Wagner DL, et al. Journal article Inflammation-induced glycolytic switch controls suppressivity of mesenchymal stem cells via STAT1 glycosylation (2019) Jitschin R, Böttcher M, Saul D, Lukassen S, Bruns H, Loschinski R, Ekici AB, et al. Journal article A novel immunoregulatory function of beta-2-microglobulin as a promoter of myeloid derived suppressor cell induction (2019) Bruns H, Jitschin S, Gamali S, Saul D, Böttcher M, Mackensen A, Jitschin R, Mougiakakos D Journal article European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias (2018) Gavriatopoulou M, Musto P, Caers J, Merlini G, Kastritis E, Van De Donk N, Gay F, et al. Journal article, Review article Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) (2018) Larocca A, Dold SM, Zweegman S, Terpos E, Waesch R, D'Agostino M, Scheubeck S, et al. Journal article, Review article Prevention and management of adverse events of novel agents in multiple myeloma: A consensus of the European Myeloma Network (2018) Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, et al. Journal article, Review article CAR T-cells targeting FLT3 have potent activity against FLT3-ITD+AML and act synergistically with the FLT3-inhibitor crenolanib (2018) Jetani H, Garcia-Cadenas I, Nerreter T, Thomas S, Rydzek J, Briones Meijide J, Bonig H, et al. Journal article JAM-A as a prognostic factor and new therapeutic target in multiple myeloma (2018) Solimando AG, Brandl A, Mattenheimer K, Graf C, Ritz M, Ruckdeschel A, Stuehmer T, et al. Journal article Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV (2018) Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, et al. Journal article